⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Human Albumin (Plasma Therapy)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-23 — Human Albumin Combined With Plasma Exchange for Frailty Intervention: Planned exploratory RCT (n=34) will test plasma exchange + human albumin (±IVIg) over 6 sessions across 5 months for frailty outcomes; protocol only, no efficacy readout. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Human Albumin Combined With Plasma Exchange for Frailty Intervention
23-sep-2026
novelty 3
per-area 3
strengthens